Table 2.
Long-term ATC survivorsa (n = 14) | Other ATC patients (n = 29) | p | |
---|---|---|---|
Mean age (years) | 67.0 (±7.0) | 73.8 (±10.0) | 0.03 |
Age >70 years | 4 (28.6%) | 21 (72.4%) | 0.006 |
F/M ratio | 0.75/1 | 1.9/1 | 0.16 |
Coexistence with DTC | 8/14 (61.5%) | 12/29 (42.9%) | 0.27 |
Tumor size (cm, M ± SD) | 4.9 (±1.6) | 6.0 (±2.5) | 0.23 |
Extrathyroid invasionb | 5/10 (50%) | 22/27 (81.5%) | 0.06 |
Stage | |||
IV A (n = 16) | 8/14 (57.1%) | 8/29 (27.6%) | 0.06 |
IV B + IV C (n = 27) | 6/14 (42.9%) | 21/29 (72.4%) |
aSurviving beyond 2 years.
bAvailable only in the 37/43 patients.